Incidence of hypertension in HAN and MON of rural Chinese.

<p>95%CI: 95% confidence interval;</p>*<p><i>P</i><0.05, compared with HAN populations.</p

Baseline characteristics of study participants.

*<p>Mean ± SD; BP, blood pressure; BMI: body mass index.</p

Additional file 1: of Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy

Table S1. Distribution of study patients treated with antihypertensive and lipid lowering drug treatment in different departments. (DOC 45 kb

Changes of CrPre, Cr_maxPost, ΔCr and %ΔCr in Patients with ARAS and Undergoing Cardiac surgery.

<p>ARAS: atherosclerotic renal artery stenosis; OPCAB: cardiopulmonary bypass; OPCAB: off-pump coronary bypass; CrPre: CrPre: preoperative creatinine; CrmaxPost: peak postoperative creatinine; ΔCr: difference between preoperative creatinine and postoperative creatinine; %ΔCr: percentage change of creatinine.</p

Adjusted hazards ratio for hypertension in Mongolian of rural Chinese.

<p>HR: hazards ratio; 95%CI: 95% confidence interval;</p>*<p>adjusted for age, high school education, family history of hypertension, drinking, prehypertension, BMI, physical activity.</p

Adjusted hazards ratio for hypertension in HAN of rural Chinese.

<p>HR: hazards ratio; 95%CI: 95% confidence interval;</p>*<p>adjusted for age, high school education, family history of hypertension, drinking, smoking, prehypertension, BMI, physical activity.</p

Flow Chart of Study Selection.

<p>Flow chart shows literature search for relevant studies about the association between ARB-based therapy and risk of cancer.</p

Additional file 3: of Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy

Table S3. Both blood pressure and LDL-C goal attainment rates of study patients based on different antihypertensive or lipid-lowering treatments in different departments. (DOC 50 kb